Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia
Clinical trial NCT01222143 · TERMINATED
Trial details
- NCT number
- NCT01222143
- Sponsor
- University Health Network, Toronto
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2015-04-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.